Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma

Completed

• Conditions: Distal Cholangiocarcinoma; Adjuvant Chemotherapy

• Registration Number: NCT06671431
• Lead Sponsor: Seoul National University Hospital

Brief Summary

Recent studies addressing the role of adjuvant chemotherapy in cholangiocarcinoma (CCA) have been published; however, there are challenges in generalizing the findings due to different prognostic characteristics depending on tumor location and resectability. Therefore, the aim of this study was to investigate the role of AC in distal cholangiocarcinoma, a common tumor subtype of CCA.

Detailed Description

Not available

Study Timeline

• Study Start: 2000-01-01
• Primary Completion: 2021-12-31
• Status Verified: 2024-10
• Study Completion: 2024-10-01
• Study First Submitted: 2024-10-31
• Study First Submitted QC: 2024-10-31
• Last Update Submitted: 2024-10-31
• Study First Posted: 2024-11-04
• Last Update Posted: 2024-11-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 578

Inclusion Criteria

• Patients with distal cholangiocarcinoma who underwent surgery

Exclusion Criteria

• Who underwent neoadjuvant treatment
• Who underwent R2 resection
• Non-adenocarcinoma patients in final pathology report
• Insufficient data
• Death within 90days of surgery

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma	From January 2000 to December 2021